- Review
ERAP1 and ERAP2 Enzymes: A Protective Shield for RAS against COVID-19?
- Silvia D’Amico,
- Patrizia Tempora,
- Valeria Lucarini,
- Ombretta Melaiu,
- Stefania Gaspari,
- Mattia Algeri and
- Doriana Fruci
Patients with coronavirus disease 2019 (COVID-19) have a wide variety of clinical outcomes ranging from asymptomatic to severe respiratory syndrome that can progress to life-threatening lung lesions. The identification of prognostic factors can help...